Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML
Clinical trial NCT05662904 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05662904
- Sponsor
- German Cancer Research Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2028-01-01
- Primary completion
- 2029-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.